In 2018 GALVmed marks 10 years of activities focused on bringing effective livestock vaccines, medicines & diagnostics to millions of smallholder farmers in sub-Saharan Africa and South Asia
Read our GALVmed@10 report on achievements and lessons learned
Ten products have been delivered in the past decade.
Proof of concepts achieved for eight products.
A significant increase in scope and scale over a relatively short period.
The estimated value of livestock disease mortalities that has been averted is USD 167 million.
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
GALVmed partner Hester Biosciences Limited has launched a campaign to sensitise farmers about animal health and management. The campaign is one of the initiatives to kick start a new programme which aims to provide over …
A field study to explore the practical viability of non-invasive, simultaneous administration of commercial Fowl Pox and Newcastle Disease vaccines could potentially help to control both diseases for smallholder farmers. The study is currently being …
Some projects funded under the just concluded phase of Protecting Livestock II are already showing promising signs of sustainability. The projects that were implemented with Hester Biosciences in India were aimed at distributing a new …
